Zum Hauptinhalt springen
CDC Website

Search Results

Funding Category

Eligible Organizations

Deadline

Standorte

Date

Results 41 - 50 of 69

Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune...

Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
US Department of Health and Human Services National Institutes of Health

The purpose of this FOA is to provide a method for investigators to request gap filling preclinical services to academic and private institutions to assist with product development efforts and facilitate the advancement of promising therapeutics for HIV and HIV-associated co-infections (Hepatitis B...

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with...

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with cancer; assesses...

Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The objective of this Notice of Funding Opportunity (NOFO) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and...

Next Generation Multipurpose Prevention Technologies

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and...

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
US Department of Health and Human Services National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact...

Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to...

Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to...

Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and substance use disorder (SUD) mechanistic or therapeutic research.

This NOFO requires a Plan for Enhancing Diverse Perspectives...